(Q28325304)

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

19 November 2022

1 reference

R. B. Stricker

1

1 reference

Europe PubMed Central

PubMed ID

1769706

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1769706

19 November 2022

B. F. Elswood

2

1 reference

Europe PubMed Central

PubMed ID

1769706

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1769706

full work available at URL

19 November 2022

language of work or name

English

0 references

publication date

August 1991

0 references

https://api.elsevier.com/content/article/PII:016524789190169B?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

https://api.elsevier.com/content/article/PII:016524789190169B?httpAccept=text/plain

19 November 2022

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

19 November 2022

0 references

29

0 references

page(s)

191-6

0 references

issue

3

0 references

cites work

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

2

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease.

19 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

The detection of human immunodeficiency virus DNA in dendritic cells from the joints of patients with aseptic arthritis

19 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Most CD4+ T cells from human immunodeficiency virus-1 infected patients can undergo prolonged clonal expansion

19 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex

19 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Retroviruses in dermatology

19 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Epidermal Langerhans cells--a target for HTLV-III/LAV infection.

19 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Langerhans cells in HIV-1 infection

19 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

The human immunodeficiency virus long terminal repeat is preferentially expressed in Langerhans cells in transgenic mice

19 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

The New England Journal of Medicine

19 November 2022

14

118

481

Belsito

1984

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Prognostic value of Langerhans cells in the epidermis of HIV patients

19 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Structural and functional relationships between epidermal Langerhans cells and dendritic cells.

19 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function

19 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture

19 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Dendritic cells in contact sensitivity

19 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Role of epidermal Langerhans cells in viral infections

19 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity

19 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV.

19 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Correction of human immunodeficiency virus-associated depression of delayed-type hypersensitivity (DTH) after zidovudine therapy: DTH, CD4+ T-cell numbers, and epidermal Langerhans cell density are independent variables

19 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

The hapten in contact hypersensitivity to dinitrochlorobenzene: immunoelectron microscopic and immunofluorescent studies

19 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

The distribution of 2,4-dinitrophenyl groups on Thy-1 positive cells in the epidermis of mouse following skin painting with 2,4-dinitrochlorobenzene

19 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Induction of allergic contact dermatitis in patients with the lymphoma-leukemia complex

19 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

The interference phenomenon in allergic contact dermatitis

19 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

A method for dinitrochlorobenzene contact sensitization. A clinicopathological study

19 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Immunotherapy of verrucae vulgares with dinitrochlorobenzene

19 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Treatment of the common wart by induced allergic inflammation

19 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Dinitrochlorobenzene immunotherapy for verrucae resistant to standard treatment modalities

19 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Contact immunotherapy of resistant warts

19 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Therapeutic effect of dinitrochlorobenzene (DNCB) on verruca plana and verruca vulgaris

19 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration

19 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Proceedings: Epidermolysis bullosa

19 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Induction of hair growth in alopecia areata with D.N.C.B.

19 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Dinitrochlorobenzene Therapy for Alopecia Areata

19 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Antigenic competition as a therapeutic concept for alopecia areata

19 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions

19 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Reduced density and morphologic alteration of Ia and ADPase positive Langerhans cells after low-protein diet

19 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Sex differences in susceptibility to development of contact hypersensitivity to dinitrochlorobenzene (DNCB).

19 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Suppression of Contact Sensitization in Man by Prior Feeding of Antigen

19 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Potential hazards of dinitrochlorobenzene (DNCB) disputed

19 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Lack of cross-reaction between DNCB and chloramphenicol

19 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Circuits and signals of the skin-associated lymphoid tissues (SALT).

19 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Regulation by the skin of lymphoid cell recirculation and localization properties

19 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Changes in lymphocyte and Langerhans cell populations in allergic and irritant contact dermatitis

19 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

ATPase and morphologic changes in Langerhans cells induced by epicutaneous application of a sensitizing dose of DNFB.

19 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus.

19 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Stimulation of T-cellular immunity by cutaneous application of dinitrochlorobenzene

19 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

Severe Allergic Contact Dermatitis From Dinitrochlorobenzene in a Patient With Human Immunodeficiency Virus Infection

19 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90169-B

19 November 2022

Identifiers